Open access
Open access
Powered by Google Translator Translator

Chest Medicine

Study Addresses Clinical Validity and Utility of Serum Antibodies to SARS-CoV-2

7 Jul, 2020 | 08:55h | UTC

Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case–Control Study – Annals of Internal Medicine

 


A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic

7 Jul, 2020 | 08:54h | UTC

A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic – The American Journal of Medical Sciences

 


Study Publications Must Be Up-To-Date in Covid Time (Regarding the Latest Observational Hydroxychloroquine Study)

6 Jul, 2020 | 09:00h | UTC

Study Publications Must Be Up-To-Date in Covid Time – Absolutely Maybe Blog, by Hilda Bastian

Original Study: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 – International Journal of Infectious Diseases

 


Opinion – One U.K. Trial is Transforming COVID-19 Treatment. Why Haven’t Others Delivered More Results?

6 Jul, 2020 | 08:58h | UTC

One U.K. trial is transforming COVID-19 treatment. Why haven’t others delivered more results? – Science

Study 1 – lopinavir-ritonavir: No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY

Study 2 – dexamethasone: Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 – Recovery Trial AND Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report – medRxiv

Study 3 – hydroxychloroquine: No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19

 


WHO Discontinues Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19

6 Jul, 2020 | 09:02h | UTC

WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19 – World Health Organization

Commentary: WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths – The Guardian

 

Related Commentary on Twitter

 


239 Experts With 1 Big Claim: The Coronavirus Is Airborne

6 Jul, 2020 | 08:57h | UTC

239 Experts With 1 Big Claim: The Coronavirus Is Airborne – The New York Times

“… in an open letter to the W.H.O., 239 scientists in 32 countries have outlined the evidence showing that smaller particles can infect people, and are calling for the agency to revise its recommendations. The researchers plan to publish their letter in a scientific journal next week.”

 


[Preprint] Randomized Trial: Convalescent Plasma for COVID-19

6 Jul, 2020 | 08:47h | UTC

Convalescent Plasma for COVID-19. A randomized clinical trial – medRxiv

 

Related Commentary on Twitter

https://twitter.com/hildabast/status/1279625347214921729

 


Meta-Analysis: Acute Complications and Mortality in Hospitalized Patients with Covid-19

6 Jul, 2020 | 08:36h | UTC

Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis – Critical Care

 


Randomized Trial: Ambulatory Management of Primary Spontaneous Pneumothorax

6 Jul, 2020 | 08:29h | UTC

Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial – The Lancet

 


Covid-19: Viral Loads in Upper Respiratory Specimens Peak by 2-3 Days from Symptom Onset and Decrease Rapidly Thereafter

3 Jul, 2020 | 08:40h | UTC

Distribution of Transmission Potential during Non-Severe COVID-19 Illness – Clinical Infectious Diseases

 

Related Commentary on Twitter

 


Meta-Analysis: Diagnostic Accuracy of Serological Tests for Covid-19

2 Jul, 2020 | 08:54h | UTC

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis – The BMJ

 

Related Commentary on Twitter

 


Meta-Analysis: The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus

2 Jul, 2020 | 08:51h | UTC

The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries – PLOS One

 


Visualizing the Effectiveness of Face Masks in Obstructing Respiratory Jets

2 Jul, 2020 | 08:47h | UTC

Visualizing the effectiveness of face masks in obstructing respiratory jets – Physics of Fluids

Commentaries: New Paper Shows Why Face Masks Are Essential In Curbing Covid-19 – Forbes AND Face Mask Construction, Materials Matter for Containing Coughing, Sneezing Droplets – American Institute of Physics

 


Evidence Does Not Support Vitamin D for Reducing Respiratory Infections, Reviews Conclude

2 Jul, 2020 | 08:42h | UTC

Evidence does not support vitamin D for reducing respiratory infections, reviews conclude – The BMJ

 


[Abstract Only] Randomized Trial: Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

2 Jul, 2020 | 08:39h | UTC

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD – New England Journal of Medicine

Commentaries: Triple Therapy at 2 Doses Appears to Reduce COPD Exacerbations, Study Says – AJMC AND Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD – Physician’s Weekly

 


Update of the Treatment of Nosocomial Pneumonia in the ICU

2 Jul, 2020 | 08:37h | UTC

Update of the treatment of nosocomial pneumonia in the ICU – Critical Care

 


Editorial: Is a “Cytokine Storm” Relevant to COVID-19?

1 Jul, 2020 | 07:59h | UTC

Is a “Cytokine Storm” Relevant to COVID-19? – JAMA Internal Medicine

 

Related Commentary on Twitter

 


Meta-Analysis: Outcomes from Intensive Care in Patients with COVID‐19

1 Jul, 2020 | 07:46h | UTC

Outcomes from intensive care in patients with COVID‐19: a systematic review and meta‐analysis of observational studies – Anaesthesia

 


Why COVID-19 Silent Hypoxemia is Baffling to Physicians

1 Jul, 2020 | 07:48h | UTC

Why COVID-19 Silent Hypoxemia is Baffling to Physicians – American Journal of Respiratory and Critical Care Medicine

Commentary: Silent Hypoxemia from COVID-19 Explained – Journal Feed

 


[Abstract Only] Meta-Analysis: The Prognostic Value of Syncope on Mortality in Patients with Pulmonary Embolism

1 Jul, 2020 | 07:31h | UTC

The Prognostic Value of Syncope on Mortality in Patients With Pulmonary Embolism: A Systematic Review and Meta-analysis – Annals of Emergency Medicine

Commentary: Does Syncope in PE Mean Increased Mortality? – Journal Feed

 


Press Release: No Clinical Benefit from Use of Lopinavir-ritonavir in Hospitalized COVID-19 Patients

30 Jun, 2020 | 08:08h | UTC

No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY

Commentary: Expert reaction to statement from RECOVERY trial on lopinavir-ritonavir in hospitalised COVID-19 patients, reporting no clinical benefit – Science Media Centre

 


[Preprint] Immunity to COVID-19 is Probably Higher than Tests Have Shown

30 Jun, 2020 | 08:04h | UTC

Immunity to COVID-19 is probably higher than tests have shown – Karolinska Institutet

Original Study: Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 – bioRxiv

 


Opinion – Coronavirus: Could it be Burning out After 20% of a Population is Infected?

30 Jun, 2020 | 08:00h | UTC

Coronavirus: could it be burning out after 20% of a population is infected? – The Conversation

 


Opinion: Why N95 Should Be the Standard for All COVID-19 Inpatient Care

30 Jun, 2020 | 07:54h | UTC

Why N95 Should Be the Standard for All COVID-19 Inpatient Care – Annals of Internal Medicine

 


NICE Evidence Summary: Vitamin D Not Indicated to Prevent or Treat COVID-19

30 Jun, 2020 | 07:56h | UTC

COVID-19 rapid evidence summary: vitamin D for COVID-19 – National Institute for Health and Care Excellence

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.